OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An algorithmic approach for the treatment of severe uncontrolled asthma
Εleftherios Ζervas, Κonstantinos Samitas, Andriana Ι. Papaioannou, et al.
ERJ Open Research (2018) Vol. 4, Iss. 1, pp. 00125-2017
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
Steven G. Kelsen, Ioana Agache, Weily Soong, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 3, pp. 790-798
Open Access | Times Cited: 209

Severe Eosinophilic Asthma
Agamemnon Bakakos, Stelios Loukides, Petros Bakakos
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 97

New biological treatments for asthma and skin allergies
Stefanie Eyerich, Martin Metz, Apostolos Bossios, et al.
Allergy (2019) Vol. 75, Iss. 3, pp. 546-560
Open Access | Times Cited: 83

Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life
Fabio Luigi Massimo Ricciardolo, Andrea Elio Sprio, Andrea Baroso, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 61

Phenotype overlap in the natural history of asthma
Fabio Luigi Massimo Ricciardolo, Giuseppe Guida, Francesca Bertolini, et al.
European Respiratory Review (2023) Vol. 32, Iss. 168, pp. 220201-220201
Open Access | Times Cited: 30

Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation
С. Н. Авдеев, Natalia Nenasheva, Kirill Zhudenkov, et al.
PULMONOLOGIYA (2018) Vol. 28, Iss. 3, pp. 341-358
Open Access | Times Cited: 64

Treating severe asthma: Targeting the IL‐5 pathway
Stefania Principe, Celeste Porsbjerg, Sisse B. Ditlev, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 8, pp. 992-1005
Open Access | Times Cited: 51

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion
Roland Buhl, Elisabeth H. Bel, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 2, pp. 422-432
Open Access | Times Cited: 45

Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis
Mingjin Yang, Yan Zhang, Hong Chen, et al.
Infection (2018) Vol. 47, Iss. 3, pp. 377-385
Closed Access | Times Cited: 53

International severe asthma registry (ISAR): protocol for a global registry
J. Mark FitzGerald, Trung N. Tran, Marianna Alacqua, et al.
BMC Medical Research Methodology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study
Takanori Numata, Jun Araya, Hanae Miyagawa, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 609-618
Open Access | Times Cited: 36

Updated biomarkers for extracellular traps from neutrophil, monocyte, and M1 macrophage in neutrophilic asthma: a narrative review
Quang Luu Quoc, Thi Bich Tra Cao, Hae‐Sim Park, et al.
Y HOC TP HO CHI MINH (2025) Vol. 9, Iss. 1, pp. 1-16
Closed Access

The evolving algorithm of biological selection in severe asthma
Nikolaos G. Papadopoulos, Peter J. Barnes, Giorgio Walter Canonica, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1555-1563
Open Access | Times Cited: 37

Switching between biologics in severe asthma patients. When the first choice is not proven to be the best
Andriana Ι. Papaioannou, Evangelia Fouka, Despina Papakosta, et al.
Clinical & Experimental Allergy (2020) Vol. 51, Iss. 2, pp. 221-227
Closed Access | Times Cited: 36

Unanswered questions on the use of biologics in pediatric asthma
Antonio Nieto, Zeinab A. El-Sayed, René Maximiliano Gómez, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 11, pp. 100837-100837
Open Access | Times Cited: 11

Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment
Amelia Licari, Riccardo Ciprandi, Gian Luigi Marseglia, et al.
Behavioral Sciences (2019) Vol. 9, Iss. 7, pp. 78-78
Open Access | Times Cited: 31

Perioperative management of patients with asthma during elective surgery: A systematic review
Samuel Debas Bayable, Debas Yaregal Melesse, Girmay Fitiwi Lema, et al.
Annals of Medicine and Surgery (2021) Vol. 70, pp. 102874-102874
Open Access | Times Cited: 23

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
Corrado Pelaia, Claudia Crimi, Santi Nolasco, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1822-1822
Open Access | Times Cited: 23

Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma
Eugene R. Bleecker, Deborah A. Meyers, Dean Billheimer, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1805-1813
Open Access | Times Cited: 8

A real-world assessment of asthma with chronic rhinosinusitis
Fabio Luigi Massimo Ricciardolo, Stefano Levra, Andrea Elio Sprio, et al.
Annals of Allergy Asthma & Immunology (2020) Vol. 125, Iss. 1, pp. 65-71
Closed Access | Times Cited: 21

Biologics in severe asthma: the overlap endotype - opportunities and challenges
Agamemnon Bakakos, Stelios Loukides, Omar S. Usmani, et al.
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 12, pp. 1427-1434
Closed Access | Times Cited: 20

Therapeutic efficacy of IL-17A neutralization with corticosteroid treatment in a model of antigen-driven mixed-granulocytic asthma
Katherine Menson, Madeleine M. Mank, Leah Reed, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 4, pp. L693-L709
Open Access | Times Cited: 18

Roles of real-world evidence in severe asthma treatment: challenges and opportunities
Young‐Soo Lee, Ji‐Hyang Lee, So Young Park, et al.
ERJ Open Research (2022) Vol. 9, Iss. 2, pp. 00248-2022
Open Access | Times Cited: 9

Discriminatory Molecular Biomarkers of Allergic and Nonallergic Asthma and Its Severity
Selene Baos, David Calzada, Lucía Cremades‐Jimeno, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 15

The Future of Asthma Care
Stephen T. Holgate, Samantha Walker, Brigitte West, et al.
Clinics in Chest Medicine (2019) Vol. 40, Iss. 1, pp. 227-241
Closed Access | Times Cited: 14

Page 1 - Next Page

Scroll to top